Literature DB >> 6509456

Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

R E Slayton, J A Blessing, H D Homesley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6509456

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy for advanced or recurrent carcinoma of the cervix.

Authors:  J D Bloss
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

Review 2.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

3.  A screening of a library of T7 phage-displayed peptide identifies E2F-4 as an etoposide-binding protein.

Authors:  Mihoko Takami; Yoichi Takakusagi; Kouji Kuramochi; Senko Tsukuda; Satoko Aoki; Kengo Morohashi; Keisuke Ohta; Susumu Kobayashi; Kengo Sakaguchi; Fumio Sugawara
Journal:  Molecules       Date:  2011-05-24       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.